DC Devices, a developer of medical devices, has raised $10.7 million in a venture capital round, the company disclosed in new filing with the Securities and Exchange Commission. Ten separate investors participated in the offering.

Founded in 2009 and backed by General Catalyst Partners, DC Devices is developing medical devices for the treatment of congestive heart failure. DC Devices is developing the first trans-catheter device for diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). The company's proprietary and innovative IASD™ (Inter-Atrial Shunt Device) system is minimally invasive and is designed to relieve increased left atrial pressure (LAp), the main cause of DHF/HFpEF symptoms.